ARMI CTO Dr. Tom Bollenbach will moderate manufacturing and AI sessions at an NIH workshop focused on advancing cell-replacement therapies for type 1 diabetes.
Join ARMI at Cell & Gene Therapy International during Biotech Week Boston, where Chief Regulatory Officer Dr. Richard McFarland will moderate a panel on decentralized manufacturing for cell therapies.
Meet ARMI | BioFabUSA at the 2026 Cambridge Science Carnival and explore regenerative manufacturing, STEM education and biomanufacturing careers.
ARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry's leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
